Mass SARS-CoV-2 serological screening, a population-based study in the Principality of Andorra.

Royo-Cebrecos, Cristina; Vilanova, David; López, Joel; Arroyo, Vanesa; Pons, Marc; Francisco, Guillem; Carrasco, Mireia G; Piqué, Josep M; Sanz, Sergi; Dobaño, Carlota; García-Basteiro, Alberto L.

Afiliação

Royo-Cebrecos C; Internal Medicine Department of Hospital Nostra Senyora de Meritxell, Escaldes-Engordany, Andorra.
Vilanova D; Andorra Health Services (SAAS), Escaldes-Engordany, Andorra.
López J; Genomictales, Escaldes-Engordany, Andorra.
Arroyo V; Genomictales, Escaldes-Engordany, Andorra.
Pons M; Andorra Innovation Hub, Andorra la Vella, Andorra.
Francisco G; Andorra Innovation Hub, Andorra la Vella, Andorra.
Carrasco MG; Andorran Research Institute (IEA), Andorra La Vella, Andorra.
Piqué JM; Andorra Innovation Hub, Andorra la Vella, Andorra.
Sanz S; Andorran Ministry of Health, Andorra La Vella, Andorra.
Dobaño C; Andorra Health Services (SAAS), Escaldes-Engordany, Andorra.
García-Basteiro AL; ISGlobal, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.